Unknown

Dataset Information

0

Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging.


ABSTRACT: Objectives:To evaluate the clinicopathological differences between Prostate Imaging-Reporting and Data System (PI-RADS) version 2 (v2) category 1 and 2 groups. Materials and Methods. We retrospectively reviewed our two institutional clinical databases: (1) transrectal ultrasound (TRUS)/magnetic resonance imaging (MRI) fusion biopsy cohort (n = 706) and (2) radical prostatectomy (RP) cohort (n = 1403). Subsequently, we performed comparative analyses between PI-RADSv2 category 1 and 2 groups. Clinically significant prostate cancer (csPCa) was defined as the presence of Gleason score (GS) ? 3 + 4 in a single biopsy core, and adverse pathology (AP) was defined as high-grade (primary Gleason pattern 4 or any pattern 5) and/or non-organ-confined disease (pT3/N1). We also performed multivariate logistic regression analyses for AP. Results:In the TRUS/MRI fusion biopsy cohort, no significant differences in detection rates of all cancer (18.2% vs. 29.0%, respectively, P = 0.730) or csPCa (9.1% vs. 9.9%, respectively, P = 0.692) were observed between PI-RADSv2 category 1 and 2 groups. There were no significant differences in pathologic outcomes including Gleason score (?4 + 3, 21.2% vs. 29.9%, respectively, P = 0.420) or detection rate of AP (27.3% vs. 33.8%, respectively, P = 0.561) between the two groups in the RP cohort either. PI-RADSv2 category 1 or 2 had no significant association with AP, even in univariate analysis (P = 0.299). Conclusions:PI-RADSv2 categories 1 and 2 had similar performance to predict clinicopathological outcomes. Consequently, these two categories may be unified into a single category. Negative mpMRI does not guarantee the absence of AP, as with csPCa.

SUBMITTER: Kim JK 

PROVIDER: S-EPMC7154969 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging.

Kim Jung Kwon JK   Lee Hak Jong HJ   Hwang Sung Il SI   Choe Gheeyoung G   Hong Sung Kyu SK  

BioMed research international 20200331


<h4>Objectives</h4>To evaluate the clinicopathological differences between Prostate Imaging-Reporting and Data System (PI-RADS) version 2 (v2) category 1 and 2 groups. <i>Materials and Methods</i>. We retrospectively reviewed our two institutional clinical databases: (1) transrectal ultrasound (TRUS)/magnetic resonance imaging (MRI) fusion biopsy cohort (<i>n</i> = 706) and (2) radical prostatectomy (RP) cohort (<i>n</i> = 1403). Subsequently, we performed comparative analyses between PI-RADSv2  ...[more]

Similar Datasets

| S-EPMC6595160 | biostudies-literature
| S-EPMC8021423 | biostudies-literature
| S-EPMC5033350 | biostudies-literature
| S-EPMC7984719 | biostudies-literature
| S-EPMC6504619 | biostudies-literature
| S-EPMC6946904 | biostudies-literature
| S-EPMC6499813 | biostudies-literature
| S-EPMC5369010 | biostudies-literature
| S-EPMC6116681 | biostudies-literature
| S-EPMC6690492 | biostudies-literature